The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Pear Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q4 2022.
Pear Therapeutics, Inc. Current Ratio for the quarter ending December 31, 2022 was 232 %, a 34.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period
Value
YoY Chg
Change %
Date
Q4 2022
232
-121
-34.3%
Dec 31, 2022
Q3 2022
294
+18
+6.53%
Sep 30, 2022
Q2 2022
317
Jun 30, 2022
Q1 2022
339
Mar 31, 2022
Q4 2021
353
Dec 31, 2021
Q3 2021
276
Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.